Also Read: Covid vaccine: 129 crore doses provided to states, UTs, says Health Ministry First, some good news One recent study found a commonly prescribed drug for depression, fluvoxamine, given to people diagnosed with COVID-19 reduced their chance of symptoms deteriorating, needing to go to hospital, and dying.
There are four powerful features of this study. It was based on: - An existing human drug: drugs designed for another purpose can have extra therapeutic benefits.
We also didn’t have to design a drug from scratch and knew a lot about tolerated doses, side-effects and drug interactions, over many years of people taking it. - Earlier observation and data: the drug was chosen based on prior data showing people taking the same or